“TRANSHUMAN” HHS ARPA-H Award – 3D BioPrinting of Organs Made from Nanotechnology Hydrogels FRESH at Carnegie Mellon University
The Transhuman Vision of Future Humans is moving forward
by Fabio Giuseppe Carlo Carisio
The Transhuman Vision of future Humans is moving forward. Carnegie Mellon University is leading the charge by a recent funding from ARPA-H to 3 D print livers.
ARPA-H is modeled after DARPA, the Defense Advanced Research Projects Agency, and both agencies focus on high-risk, high-impact research. While DARPA primarily develops technologies for military use, ARPA-H aims to advance health and biomedical research to solve critical health challenges.
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the United States Department of Health and Human Services (now led by attorney Robert F. Kennedy jr.).
The issue appears very delicate, especially in light of the scandal caused a few years ago by the experiment of a Chinese scientist (later convicted) who experimented on two newborns with gene editing using CRISP/Cas, the basic biotechnology used for the creation of mRNA genetic serums.
Here then arises a huge bioethical problem on the limits of science which through biochemical engineering is capable of carrying out extreme experiments in correlation with the potential of Artificial Intelligence well described in the video we publish below and entitled: “The Darkside of AI – Transhumanism and the War Against Humanity”.
But now let’s look in detail at the new challenge of transhumanism recalling that in the Stargate AI Project funded by Trump Administration one of the main supporters of this anti-human scientific evolution was also included.
From a strictly medical perspective, there is the possibility that these new experimental biotechnologies could cause even more adverse reactions than mRNA vaccines.
From a social perspective, there is also the suspicion that these “artificial organs” could contain components that control the individual, capable of influencing their existence and free will.
University of Pittsburgh: “Could 3D-Printed Organs End the Donor Shortage?”
The project is well detailed by Kat Procyk in an article titled “Could 3D-Printed Organs End the Donor Shortage?” published on website of University of Pittsburgh, School of Medicine.
«LIVE will leverage Carnegie Mellon’s Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting to fabricate biological livers made entirely from human cells and structural proteins such as collagen. The idea is that the liver will be able to be placed in patients for about two to four weeks while their own liver regenerates, meaning those patients won’t need a full transplant. Once the patient has recovered, the bioprinted liver is naturally rejected and reabsorbed by the body»..
When Alejandro Soto-Gutiérrez was growing up in Latin America, it was nearly impossible for people with organ failure to get transplants. He lost his uncle nearly 25 years ago to liver cirrhosis, shaping his career.
“Only those who could either pay for the immunosuppressants, which are necessary for transplants to prevent rejection, or the very few who could get the treatment for free were the only groups receiving transplants in Mexico at the time,” said Soto-Gutiérrez, Professor of Experimental Pathology and faculty member of the Thomas E. Starzl Transplantation Institute, University of Pittsburgh, School of Medicine. “I knew from that moment on that I wanted to tackle the organ transplant shortage.”
This publication was supported by the Advanced Research Projects Agency for Health (ARPA-H) under Award Number D25AC00460-00, providing up to $28,520,065 to Carnegie Mellon University for a 60-month period. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Advanced Research Projects Agency for Health.
Carnegie Mellon University is leading the charge by a recent funding from ARPA-H to 3 D print livers.
«As of January 2026, Soto-Gutiérrez is part of a Carnegie Mellon University-led team that received up to $28.5 million from the Advanced Research Projects Agency for Health (ARPA-H) for Liver Immunocompetent Volumetric Engineering (LIVE), a project aimed at developing a functional, 3D-bioprinted liver for patients with acute liver failure. LIVE is part of ARPA-H’s Personalized Regenerative Immunocompetent Nanotechnology Tissue program to create personalized, functional human organs and tissues on demand through 3D bioprinting».
The article by Univerity of Pittsburgh explained quoting all the projects (link in the sources)
“The goal is to create a piece of liver tissue that you can use as an alternative to transplant, specifically for acute liver failure,” said Adam Feinberg, professor of biomedical engineering at Carnegie Mellon and principal investigator in an article published by official website of Carnegie Mellon on January, 1, 2026 (link in the sources).
“The liver we are creating would last for about two to four weeks. It would give patients time for their own liver to regenerate, and then, they would not need a liver transplant, freeing up those livers for other patients. The liver is just the first application, with the plan to expand to the heart, pancreas, and other organs. This innovation would fundamentally change healthcare as we know it, because most people suffer at some point from end-stage organ failure.”
This is the biotechnology PRINT (Personalized Regenerative Immunocompetent Nanotechnology Tissue) within is developed the LIVE Carnegie Project with the Hydrogels Nanotechnology FRESH (quoted above).
«PRINT focuses on three technical areas with the end goal of restoring normal tissue function. The first technical area aims to generate the necessary cell types for organ bioprinting, via blood draw, biopsy, or biobank generation. The second technical area involves large scale manufacturing of cell types. The third technical area focuses on organ biofabrication and testing for safety and efficacy. Performers are encouraged to explore multiple methods for achieving the goals of each technical area» we can read in the Print (link in the sources).
Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting to fabricate biological livers
The goal is not just to print livers from self assembly nanotechology hydrogel, but all human organs.
«Researchers believe they can extend their bioprinting capability to other organs, including the heart and pancreas, using the liver as a blueprint. In the next decade, Soto-Gutiérrez’s ambition is building manufacturing facilities that can produce organs on demand, eliminating waiting lists for organ transplantation» the post on University of Pittsburgh website adds.
Hydrogels are crosslinked polymer chains with three-dimensional (3D) network structures, which can absorb relatively large amounts of fluid. Because of the high water content, soft structure, and porosity of hydrogels, they closely resemble living tissues. They were used in the Pentagon’s Under-Skin Microchip to detect Covid
HHS program mentioned by Kat Procyk in his article recalls:
«Today, more than 100,000 men, women and children are on the national transplant waiting list in the United States, with 13 people dying each day waiting for a transplant, according to the Health Resources and Services Administration. In continents with far more limited resources and health care disparities, those numbers are even more dire. In Africa, for example, only 286 transplants were recorded in the region in 2022, a sharp decline from the 643 transplants in 2016».
LIVE will leverage Carnegie Mellon’s Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting to fabricate biological livers made entirely from human cells and structural proteins such as collagen.
DARPA Is Working on Synthesizing DNA With Light and the Luciferian Parallels Cannot be Ignored
«The idea is that the liver will be able to be placed in patients for about two to four weeks while their own liver regenerates, meaning those patients won’t need a full transplant. Once the patient has recovered, the bioprinted liver is naturally rejected and reabsorbed by the body» highlighted the Substacl Humanity United Now published by Medical Doctor Ana Maria Mihalcea (link in the sources).
Soto-Gutiérrez’s role in the project is to define and measure the cell functions the bioprinted liver must meet for it to have a clinical benefit. The biggest challenge is overcoming the need for immunosuppressive medications, which can damage a patient’s organs or other systems in the body.
DARPA-GATES! ECHO Program: Human DNA Hunting by Pentagon’s Military Agency BTO
The livers will be built using hypoimmune cells—engineered to function as universal donor cells so recipients can receive these tissues without needing immune‑suppressing drugs.
“Imagine eliminating immune suppression for life,” said Soto-Gutiérrez. “No medications, no costs and no fear of chronic rejection. That would fundamentally change transplantation forever.”
Research on NanoMetallics also Found in Covid Vaccines
«Carnegie Mellon University is also Leader in stainless steel neural probes. I remind you that Nano-pathologist Antonietta Gatti found Steel fragments in childhood vaccines. What are they doing there?» recalled Mihalcea.
An important study revealed also the presence of heavy metal in mRNA genetic Serums.
«COVID 19 injections also were contaminated with Stainless Steel Fragments. Is that pure coincidence?» Mihalcea wondered. Also The Time published an article on “Steel fragments from factory in Moderna vaccine doses”.
These novel, customizable stainless steel neural probes, or steeltrodes, that are microfabricated using a multilayer process which enables high-density electrode integration is the focus of a paper published in Nature Communications titled “Robust minimally-invasive microfabricated stainless steel neural interfaces for high resolution recording”.
Moderna and Rovi Pharma recall 764,900 COVID-19 Vaccine doses in EU due to Contamination.
The team has demonstrated successful high resolution neural recording from the auditory cortex of test subjects:
«We demonstrate 8 cm long, ~300 µm wide probes, featuring rigid shanks with optional flexible cables for in vivo high-resolution laminar recording from macaque auditory cortex. In rats, these probes can be safely implanted through intact dura with minimal cortical damage. High-fidelity recordings of single units and local field potentials in macaques highlight the potential of steeltrodes for translation to human applications, enabling both inter- and intraoperative neural recordings» the study Ahmed et al. explained on Nature.
«One hurdle the team had to overcome was the micro- and nanofabrication process for stainless steel. In the case of silicon probes, the fabrication process has benefitted from decades of research and development in the Micro-/Nano-Electromechanical Systems (MEMS/NEMS) and Complementary metal–oxide–semiconductor (CMOS) electronic industries. However, the same processes cannot be readily translated to stainless steel. By using a multilayer fabrication process that enables high-density electrode integration, as well as optional flexible cables, Chamanzar believes these probes can be manufactured in mass» the Humanity United Now substack pointed out.
Hydrogels among the components of mRNA Genetic Serums
«Is it just coincidence that Transhumanist Ray Kurzweil accurately predicted that human organs will be 3 D printed as the Singularity nears? Kurzweil explains how the military created the network of scientists to bring forth the technocratic transhumanist dream. Remember the COVID19 bioweapon roll out was a military operation – with long ties to DARPA who funded Moderna for the development of the mRNA technology» concluded MD Ana Maria Mihalcea who was among the first to denounce the presence of dangerous nanoparticles in mRNA gene serums, including hydrogels.
We recall that this project led by virologist Anthony Fauci thanks the help of Wuhan Institute of Virology and University of North Carolina allowed Big Pharma in Cambridge, Massachusetts, also financed by Bill Gates, to develop the Spikevax Covid vaccine nine months before the first SARS-CoV-2 outbreak in China…
Moderna’s patents on mRNA genetic serums also list graphene oxide nanotubes and nanometallic Quantum Dots among their components.
This is why the evolution of biomedical research toward the production of artificial organs increasingly legitimizes the belief that SARS-CoV-2, in addition to inflicting social terrorism to justify measures restricting freedom as a psychological test, was a massive, forced mass experiment to gather data for Big Pharma, also in relation to the development of AIDS drugs and vaccines.
Fabio Giuseppe Carlo Carisio – Gospa News Director
MAIN SOURCES
University of Pittsbugh – Could 3D-Printed Organs End the Donor Shortage?
Carnegie Mellon awarded ARPA-H contract to develop 3D bioprinted liver
ARPA-H awards teams set to bioprint universally matched organs on demand
ARPA – Personalized Regenerative Immunocompetent Nanotechnology Tissue
THE TIME – Steel fragments from factory in Moderna vaccine doses
RELATED POSTS
